GlaxoSmithKline’s (GSK) Pharmaceutical Tablet Manufacturing Factory, Karnataka, India
GlaxoSmithKline (GSK) began construction of an oral solid-dose manufacturing plant at the Vemgal Industrial Area in India in September 2015.
The new facility is expected to be operational in 2017 and will produce tablets and capsules. It is expected to generate approximately 300 jobs in the Bangalore area.
It is expected to be completed with an investment of Rs10bn ($153m).
Vemgal industrial area of Bangalore, India
Bangalore was chosen to host the facility because it is a pharmaceutical and biotech hub with a large number of available skilled staff, a moderate climate, a supportive and friendly state government, and it is a central location in the southern states of India.
It was built in the Vemgal industrial area, a dedicated government-owned industrial area with good state-based investment incentives. The 50-acre site was leased for 99 years from the Karnataka Industrial Area Development Board (KIADB) in October 2014.
Tablet manufacturing in Karnataka
The new facility will manufacture more than eight billion tablets and one billion capsules a year for anti-inflammatory, gastroenterology medicines, and Vitamin products for Indian markets.
It will be designed using the GSK Production System, which aims to achieve zero accidents, defects, and waste to ensure quality. The facility will give increased access to GSK's products in India. Apart from manufacturing facilities, it will also include a warehouse, site infrastructure, employee welfare centre, and utilities to support packing of medicines.
The factory is being constructed using the latest project management techniques to ensure it becomes operational in as short a time as possible, including quality management systems and staff recruitment.
Staff will undergo rigorous training to ensure medicines are manufactured to the highest standards. GSK says all aspects of the new factory will be designed and constructed with the aim of keeping employees safe.
Sustainability features at the tablet manufacturing facility
The facility will be designed and constructed to achieve LEED Gold certification standard. It will be equipped with 0.5MW of solar photovoltaic (PV) capacity to help reduce the carbon footprint.
It will also include a fully-automated warehouse integrated with the M-ERP system. All waste water at the facility will be recycled to achieve zero waste and captured rain water will be stored in underground tanks for future use.
Research-based pharmaceutical and healthcare company GSK
Headquartered at Brentford in London, GlaxoSmithKline is a research-based pharmaceutical and healthcare company engaged in the production, development, and commercialisation of vaccines and consumer health products.
The company has five plants in India, including one in Nabha, Sonepat, and Rajahmundry, as well as two in Nashik.
GSK employs in excess of 8,300 people in the country and 98% of the company's products sold in India are produced locally.